New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines ...Middle East

PR Newswire - News
New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines
OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the publication of "A cost-consequences and budget impact analysis of blue light-guided cystoscopy with Hexvix® in patients diagnosed with non-muscle-invasive bladder cancer in France" in the...

Hence then, the article about new health economic analysis in france concludes there is insignificant cost difference between white light and blue light cystoscopy use when applying ccafu guidelines was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines )

Apple Storegoogle play

Last updated :

Also on site :



Latest News